The Oxford (AstraZeneca) ‘vaccine’ will be given to up to 300 children as young as six in experimental trials.
The trials to be conducted at Oxford university and various ‘partner’ sites including Southampton and Bristol will be testing on children between 6 – 17 years of age.
These new clinical trials have not been tested on children previously anywhere in the world and it is thought to be to test the efficiency in youngsters.
Researchers will use 300 children and treat them as guinea pigs just to assess if the coronavirus ‘vaccine’ will produce a strong immune response.
The Oxford jab is one of three experimental vaccines to have been approved for use in adults in the UK. Pfizer and Moderna are the other two approved vaccines.
The first experimental trials will begin to take place this month.
Professor Andrew Pollard, chief investigator on the Oxford vaccine trial stated:
“While most children are relatively unaffected by coronavirus and are unlikely to become unwell with the infection, it is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from vaccination… These new trials will extend our understanding of ‘control’ of SARS-CoV2 to younger age groups.”
Roughly 240 of these ‘guinea pig’ children will receive the vaccine and the others will get a ‘controlled’ meningitis jab.
The Royal College of Paediatrics and Child Health stated:
“In children, the evidence is now clear that COVID-19 is associated with a considerably lower burden of morbidity and mortality compared to that seen in the elderly… There is also some evidence that children may be less likely to acquire the infection. The role of children in transmission, once they have acquired the infection, is unclear, although there is no clear evidence that they are any more infectious than adults.”
The experimental trial is the first to assess the Oxford vaccine’s efficacy in children aged six to seventeen.
Many have taken to social media in their concern that children as young as six are now being used as nothing more than guinea pigs.
Over 14 million adults have now had their first COVID-19 vaccination. The majority of those over 50.
– – – – – –
I’m still learning my trade but I’m passionate about honest, first hand reporting. It takes a lot of time to gather genuine news, photos, videos and interviews on my own. Please support me so I can continue to produce more great content. Consider sponsoring me today.